Székely Borbála, Madaras Lilla, Szentmártoni Gyöngyvér, Szász A Marcell, Baranyák Zsuzsanna, Szittya Liliána, Torgyík László, Zergényi Eva, Borbényi Erika, Kenessey István, Korompay Anna, Langmár Zoltán, Bánhidy Ferenc, Kulka Janina, Dank Magdolna
Semmelweis Egyetem, AOK, Radiológiai és Onkoterápiás Klinika, 1082 Budapest, Ulloi út 78/a.
Magy Onkol. 2010 Mar;54(1):19-26. doi: 10.1556/MOnkol.54.2010.1.3.
The two far ends of the age at the diagnosis of breast cancer are the age of younger than 35, and that of older than 70. Most probably, these two groups of patients differ in many ways. The aim of our present study was to underline the fact that age at the diagnosis of breast cancer is indeed a prognostic factor. Between October 1995 and March 2009, 80 old and 51 young breast cancer patients were treated at the Department of Diagnostic Radiology and Oncotherapy, Semmelweis University, Budapest. The prognostic and predictive factors of the tumors were analysed together with the disease-free and overall survival data. There were statistically significant differences between the two groups concerning the menstrual and reproductive factors, histological characteristics and immunophenotype of the tumors. Tumor size, nodal status and the Nottingham Prognostic Index did not show statistically significant differences. A trend to a shorter disease-free survival, higher rate of distant metastases and disease-specific death was seen in the group of young patients, but it was not significant. Overall survival was significantly shorter in the group of young patients. Therefore, we can state that young patients have a more aggressive disease and worse outcome. There is an increased importance of self examination in these groups, since both age groups are beyond the age limits of the screening population in Hungary. The media and primary school education as well should be involved in educating women concerning this aspect. The individual follow-up of young patients with positive family history should also be established.
乳腺癌诊断年龄的两端分别是35岁以下和70岁以上。很可能,这两组患者在很多方面存在差异。我们当前研究的目的是强调乳腺癌诊断年龄确实是一个预后因素这一事实。1995年10月至2009年3月期间,布达佩斯塞梅尔维斯大学诊断放射学与肿瘤治疗科治疗了80例老年乳腺癌患者和51例年轻乳腺癌患者。对肿瘤的预后和预测因素以及无病生存期和总生存期数据进行了分析。两组在月经和生殖因素、肿瘤的组织学特征和免疫表型方面存在统计学显著差异。肿瘤大小、淋巴结状态和诺丁汉预后指数未显示出统计学显著差异。年轻患者组出现无病生存期缩短、远处转移率和疾病特异性死亡率升高的趋势,但不显著。年轻患者组的总生存期显著缩短。因此,我们可以说年轻患者的疾病更具侵袭性,预后更差。在这些人群中自我检查的重要性增加,因为这两个年龄组都超出了匈牙利筛查人群的年龄范围。媒体和小学教育也应参与对女性在这方面的教育。对于有阳性家族史的年轻患者,也应建立个体随访。